LGI1 and epilepsy: In a transgenic mouse model of epilepsy expressing a secretion-defective mutant form of human LGI1, intraperitoneal injection of 4PBA restored the binding of mutant LGI1 protein to its receptor ADAM22 and prevented the increased seizure susceptibility of the mouse model (Yokoi et al., 2015).